CORT
Corcept Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CORT fundamentals
Corcept Therapeutics (CORT) released its earnings on Nov 4, 2025: revenue was 207.64M (YoY +13.77%), missed estimates; EPS was 0.16 (YoY -60.98%), beat estimates.
Revenue / YoY
207.64M
+13.77%
EPS / YoY
0.16
-60.98%
Report date
Nov 4, 2025
CORT Earnings Call Summary for Q3,2025
- Revenue Growth: Q3 2025 revenue $207.6M (+19% YoY); 2025 guidance $800M-$850M
- FDA Milestones: relacorilant approvals expected Dec 2025 (hypercortisolism), Jul 2026 (ovarian cancer)
- Patient Expansion: 3,250 active Korlym patients (+42% YoY); transitioning to new pharmacy network
- Oncology Breakthrough: ROSELLA trial shows relacorilant + nab-paclitaxel improves ovarian cancer survival
- Future Potential: $3B-$5B annual target for relacorilant; Phase III ALS trial planned for 2026
EPS
Revenue
Revenue & Expenses
CORT has released its 2025 Q3 earnings report, with revenue of 207.64M, reflecting a YoY change of 13.75%, and net profit of 19.67M, showing a YoY change of -58.34%. The Sankey diagram below clearly presents CORT's revenue sources and cost distribution.
Key Indicators
Corcept Therapeutics (CORT) key financial stats and ratios, covering profitability, financial health, and leverage.
Corcept Therapeutics (CORT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Corcept Therapeutics (CORT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Corcept Therapeutics (CORT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Corcept Therapeutics (CORT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Corcept Therapeutics (CORT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Corcept Therapeutics's revenue and profit?What guidance did Corcept Therapeutics's management provide for the next earnings period?What is the market's earnings forecast for Corcept Therapeutics next quarter?What is Corcept Therapeutics's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Corcept Therapeutics year over year?What does Corcept Therapeutics do and what are its main business segments?What is Corcept Therapeutics's gross profit margin?What were the key takeaways from Corcept Therapeutics’s earnings call?
